(3) Before conducting randomized clinical trials, it is essential to use nanotechnology to enhance targeted drug delivery, control drug release, and increase drug solubility and bioavailability and to conduct necessary pharmacokinetic, pharmacodynamic, and toxicological studies
10.1590/s0004-27302008000600005 23 BarrettE
This progression from basic protective shells to highly engineered, responsive nanocarriers reflects a steady refinement of both materials and methods, opening new avenues for maximizing the functional impact of bioactive compounds and improving health outcomes through next-generation nutritional interventions
This is Epithalons signature mechanism and the one most cited in longevity literature
Phytochemistry 72 (7), 538556
On the other hand, the CMAP portrayed normal biphasic potentials and similar amplitudes and conduction velocities